Vinorelbine and/or Gemcitabine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Sponsor
Istituto Nazionale per lo Studio e la Cura dei Tumori
Study ID
NCT00003447
Phase
PHASE3
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
70 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of vinorelbine, gemcitabine, or both in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Key Dates

Start date
Jul 31, 1998
Status verified
Sep 2007

Study Design

Enrollment
630 participants (estimated)
Allocation
RANDOMIZED
Primary purpose
TREATMENT

Related Studies